Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
American Heart Journal|May 22, 2012
The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)Nicklaus K Slocum, P Michael Grossman, Mauro Moscucci, et al.American Heart Journal|April 6, 2010
Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registryClaire S Duvernoy, Dean E Smith, Prerana Manohar, et al.The American Journal of Cardiology|March 23, 2002
Usefulness of pulse deficit to predict in-hospital complications and mortality in patients with acute type A aortic dissectionEduardo Bossone, Vincenzo Rampoldi, Christoph A Nienaber, et al.Pharmacotherapy|December 24, 2002
Health-related quality of life in patients 7 months after a myocardial infarction: factors affecting the Short Form-12Christopher R McBurney, Kim A Eagle, Eva M Kline-Rogers, et al.American Heart Journal|April 30, 2013
Current medical management of stable coronary artery disease before and after elective percutaneous coronary interventionAmer K Ardati, Bertram Pitt, Dean E Smith, et al.Archives of Internal Medicine|July 19, 2002
The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromesMark A Meier, Wisam H Al-Badr, Jeanna V Cooper, et al.JACC. Cardiovascular Interventions|August 21, 2010
Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registrySanti Trimarchi, Dean E Smith, David Share, et al.The Journal of Invasive Cardiology|October 15, 2010
The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)Michael C Reed, Mauro Moscucci, Dean E Smith, et al.Nature Chemistry|June 20, 2018
A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S]2+ clusterKevin J McDonnell, Joseph A Chemler, Phillip L Bartels, et al.American Heart Journal|September 20, 2005
Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)Rabeea Aboufakher, Arthur Riba, Sandeep M Jani, et al.Pageof 6